Sera Q2 2026 net loss $9.1M; Illinois Medicaid mandates PreTRM coverage for 50K births

SERA PROGNOSTICS, INC.

Q2 2026 revenue $30K vs $17K YoY; net loss $9.1M vs $8.0M; operating expenses $10.0M vs $9.3M.
Illinois enacted law requiring Medicaid coverage for PreTRM test; covers ~50,000 annual Medicaid births.
PRIME subgroup analysis: PreTRM cut NICU admissions 22% and severe neonatal morbidity 30% in first-time mothers.
Launched fourth partnership program; payer discussions active in 20+ states; CE marking submission planned Q4 2026.
Cash $80.3M; funds operations through 2029; Mark Capone added to board.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.